Article
DNA testing for familial hypercholesterolemia: improving disease recognition and patient care.
American journal of pharmacogenomics : genomics-related research in drug development and clinical practice - 1 Jan 2002
Vergopoulos Athanasios, Knoblauch Hans, Schuster Herbert
Abstract excerpt
Cardiovascular disease is the leading cause of death worldwide and, like most chronic diseases, it has major genetic and environmental components. Among patients with coronary heart disease onset before the age of 55, about 5% of cases are attributable to heterozygous familial hypercholesterolemia (FH), a disease following autosomal dominant inheritance. About 50% of individuals with FH die before the age of 60...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
